Cirrhosis Clinical Trials

Find clinical trials for Cirrhosis. Search for Cirrhosis clinical trials in different cities and states across the United States.

Filter

Filter results

Results: 94

Study to Evaluate the Efficacy and Safety of K-877-ER and CSG452 in Participants With NASH With Liver Fibrosis

Recruiting

PHASE2

Sponsor:

Kowa Research Institute, Inc.

Location:

Montreal, Chicoutimi, Calgary, Birminghamshow 42 more

Code:

NCT05327127

Conditions

NASH

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

K-877-ER

CSG452

Placebo

CirrhosisRx CDS System

Recruiting

Sponsor:

UCLA

Location:

San Francisco

Code:

NCT05967273

Conditions

Cirrhosis

Decision Support Systems, Clinical

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

CirrhosisRx CDS

Imaging of Pathologic Fibrosis Using 68Ga-FAP-2286

Recruiting

PHASE1

Sponsor:

Thomas Hope

Location:

San Francisco

Code:

NCT05180162

Conditions

Liver Fibrosis

Pulmonary Fibrosis

Myocardial Fibrosis

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

68Ga-FAP-2286

Positron Emission Tomography (PET)

IDEAL: Intended to Determine the Effects of Seladelpar on Normalization of Alkaline Phosphatase Levels in Subjects With Primary Biliary Cholangitis (PBC) and an Incomplete Response or Intolerance to Ursodeoxycholic Acid (UDCA)

Recruiting

PHASE3

Sponsor:

Gilead Sciences

Location:

Chandler, Pasadena, Sacramento, San Franciscoshow 27 more

Code:

NCT06060665

Conditions

Primary Biliary Cholangitis

Eligibility Criteria

Sex: All

Age: 18 - 70+

Healthy Volunteers: Not accepted

Interventions

Seladelpar 10 mg

Placebo

Online Prehabilitation for Patients Awaiting Liver Transplantation

Recruiting

Sponsor:

University of Alberta

Location:

Edmonton

Code:

NCT05899231

Conditions

Cirrhosis, Liver

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Prehabilitation Programming

Flicker App for Minimal Hepatic Encephalopathy

Recruiting

Sponsor:

University of Washington

Location:

Seattle

Code:

NCT04415294

Conditions

Hepatic Encephalopathy

Eligibility Criteria

Sex: All

Age: 18 - 70+

Healthy Volunteers: Not accepted

Interventions

Critical flicker frequency

A Study to Evaluate the Safety, Tolerability, PK, and PD Effects of AZD2389 in Participants With Liver Fibrosis and Compensated Cirrhosis.

Recruiting

PHASE2

Sponsor:

AstraZeneca

Location:

Chandler, Rialto, Atlanta, Morehead Cityshow 2 more

Code:

NCT06750276

Conditions

Liver Fibrosis

Hepatic Cirrhosis

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

AZD2389

Screening for Liver Cancer With CT vs. Ultrasound in Patients With Advanced Liver Disease

Recruiting

Sponsor:

Minneapolis Veterans Affairs Medical Center

Location:

Minneapolis

Code:

NCT01350167

Conditions

Cirrhosis

End Stage Liver Disease

Hepatitis C

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Screening

Liver Cancer Prevention Randomized Control Trial

Recruiting

Sponsor:

M.D. Anderson Cancer Center

Location:

Houston

Code:

NCT05196867

Conditions

Liver Diseases

Fibrosis, Liver

Cirrhosis, Liver

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Intervention Group

Control Group

A Phase 3 Study to Evaluate the Effect of Resmetirom on Clinical Outcomes in Patients With Well-compensated NASH Cirrhosis (MAESTRO-NASH-OUTCOMES)

Recruiting

PHASE3

Sponsor:

Madrigal Pharmaceuticals, Inc.

Location:

Birmingham, Chandler, Peoria, Tucsonshow 45 more

Code:

NCT05500222

Conditions

NASH

Cirrhosis, Liver

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Resmetirom

Placebo